Cargando…
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
Extrinsic signals are implicated in breast cancer resistance to HER2-targeted tyrosine kinase inhibitors (TKIs). To examine how microenvironmental signals influence resistance, we monitored TKI-treated breast cancer cell lines grown on microenvironment microarrays composed of printed extracellular m...
Autores principales: | Watson, Spencer S., Dane, Mark, Chin, Koei, Tatarova, Zuzana, Liu, Moqing, Liby, Tiera, Thompson, Wallace, Smith, Rebecca, Nederlof, Michel, Bucher, Elmar, Kilburn, David, Whitman, Matthew, Sudar, Damir, Mills, Gordon B., Heiser, Laura M., Jonas, Oliver, Gray, Joe W., Korkola, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927625/ https://www.ncbi.nlm.nih.gov/pubmed/29550255 http://dx.doi.org/10.1016/j.cels.2018.02.001 |
Ejemplares similares
-
INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer
por: Liu, Moqing, et al.
Publicado: (2022) -
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
por: Garay, Joseph P., et al.
Publicado: (2021) -
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
por: Smith, Rebecca, et al.
Publicado: (2020) -
HER-2 gene amplification in human breast cancer without concurrent HER-2 over-expression
por: Luoh, Shiuh-Wen, et al.
Publicado: (2013) -
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
por: Korkola, James E., et al.
Publicado: (2015)